AMRN Tiesioginiai signalai | Didinkite pelną su Getagraph.com

PARDAVIMAS 112837 min ago

@ $1.160

Išleistas: 14 vas. 2024 @ 20:12

Grąža: -20.86%

Ankstesnis signalas: vas. 13 - 17:19

Ankstesnis signalas: Pirkimas

Grąža: -0.85 %

Live Chart Being Loaded With Signals

Commentary (2 geg. 2024 @ 23:00):

Stats
Šios dienos apimtis	1.47M
Vidutinė apimtis	1.53M
Rinkos kapitalizacija	375.30M
EPS	$0 ( 2024-05-01 )
Kita pelno data	( $0 ) 2024-07-31
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-6.12
ATR14	$0.00400 (0.44%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-18	Cohen Paul	Buy	179 795	Stock Option (right to buy)
2024-04-18	Cohen Paul	Buy	50 287	Restricted Stock Unit
2024-04-18	Sullivan Diane E.	Buy	179 795	Stock Option (right to buy)
2024-04-18	Sullivan Diane E.	Buy	50 287	Restricted Stock Unit
2024-04-18	Sterling Louis Iii	Buy	179 795	Stock Option (right to buy)

INSIDER POWER
88.57
Last 98 transactions
Buy: 13 429 087 \| Sell: 697 874

Tūris Koreliacija

Ilgas: 0.17 (neutral)

Trumpas: 0.89 (strong)

Signal:(77.026) Same movement expected

Amarin Corporation PLC Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
ASTR	0.96
VCNX	0.958
RSLS	0.956
MNRO	0.955
CAMP	0.954
RENT	0.954
RICK	0.953
LYT	0.953
AEMD	0.952
ENTA	0.951

10 Labiausiai neigiamai susiję koreliacijos
PRSR	-0.961
HERA	-0.956
AGGR	-0.954
GXII	-0.952
MCAA	-0.952
CRZN	-0.949
LVRA	-0.949
LEGA	-0.949
TBSA	-0.948
XFIN	-0.947

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Amarin Corporation PLC Koreliacija - Valiuta/Žaliavos

-0.35
( neutral )

0.43
( neutral )

0.00
( neutral )

0.02
( neutral )

0.00
( neutral )

0.36
( neutral )

Amarin Corporation PLC Finansinės ataskaitos

Annual	2023
Pajamos:	$308.10M
Bruto pelnas:	$202.59M (65.75 %)
EPS:	$-0.150

FY	2023
Pajamos:	$308.10M
Bruto pelnas:	$202.59M (65.75 %)
EPS:	$-0.150

FY	2022
Pajamos:	$369.19M
Bruto pelnas:	$242.48M (65.68 %)
EPS:	$-0.260

FY	2021
Pajamos:	$583.19M
Bruto pelnas:	$461.86M (79.20 %)
EPS:	$0.0200

Financial Reports:

No articles found.

Amarin Corporation PLC

Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, and eicosapentaenoic acid. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.